about
Molecular targets for flavivirus drug discoveryInhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae FamiliesRNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATPRole of Divalent Metal Cations in ATP Hydrolysis Catalyzed by the Hepatitis C Virus NS3 Helicase: Magnesium Provides a Bridge for ATP to Fuel UnwindingThe Two-component NS2B-NS3 Proteinase Represses DNA Unwinding Activity of the West Nile Virus NS3 HelicaseHepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitroHelicase inhibitors as specifically targeted antiviral therapy for hepatitis CComparative Structural Analysis of Human DEAD-Box RNA HelicasesAgents and strategies in development for improved management of herpes simplex virus infection and disease.Revisiting the central dogma one molecule at a time.Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growthDiscovering new medicines targeting helicases: challenges and recent progress.Helicase primase: targeting the Achilles heel of herpes simplex viruses.Mechanisms of HCV NS3 helicase monitored by optical tweezers.Structure-based simulations of the translocation mechanism of the hepatitis C virus NS3 helicase along single-stranded nucleic acid.Understanding helicases as a means of virus control.Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicaseHelicases - feasible antimalarial drug target for Plasmodium falciparum.Human herpes simplex labialis.Deep insights into Dictyocaulus viviparus transcriptomes provides unique prospects for new drug targets and disease interventionStructural and functional parameters of the flaviviral protease: a promising antiviral drug target.Biphenylsulfonacetic acid inhibitors of the human papillomavirus type 6 E1 helicase inhibit ATP hydrolysis by an allosteric mechanism involving tyrosine 486Identification of inhibitors of Plasmodium falciparum RuvB1 helicase using biochemical assays.Mechanism of flexibility control for ATP access of hepatitis C virus NS3 helicase.
P2860
Q21999123-7645A849-C8DF-4F4D-939B-4F505AEFC9BFQ26700087-28A19AB3-9930-43CE-A527-76A8400C053EQ27477448-86BFC30D-6CFF-4B66-BB25-B3CCCF31DB7CQ27478187-5C7EE9DF-2CAA-4D51-8712-4905B74CE7DDQ27486257-CD0C05F0-D197-4502-874F-F6CDA60ABE9FQ27486377-953BC270-7DB1-4518-B9E0-5436E9E540A7Q27488958-58D09D8C-37A2-421C-8CA9-6BB1ACC10B44Q27664991-93C41441-89D2-416C-9EA6-8F52164E772BQ30350341-89300243-E476-41F4-8BDB-0388D2670D88Q34711713-BD4B8CD3-4D23-435B-AF1B-A81028C7CB0DQ35140796-1FDB176C-0D88-4318-ADBE-E6C6E145907CQ35592783-6E672902-CDA1-45AE-AAA9-809C12DAB8ECQ35842275-C63F42B0-821B-4013-A848-1D474FF93B3EQ36078152-438F2E4A-E85E-4CF2-AD4D-EBA7267C2C24Q36246484-D4012858-061C-4FD9-AC7F-0A48C3FF5138Q36447325-9971155B-5B87-4824-8483-70C323BF4293Q36607790-EA1221BB-21AE-403C-86D3-DC5AFCB96367Q36933788-4A1F9A97-CBA0-4A48-AFD2-61EEE29C4A27Q36978247-426E43B0-9FBA-4533-B98C-C4CAB14604FDQ37307451-8B6025C1-290D-4BDD-8311-729E166B17D6Q39817292-B5F0BDBF-9229-41A3-9640-9D8AEF2489E9Q40370605-6A6FD461-E5A1-41EB-A0FE-7A9FD25A6404Q42212171-F9186B8C-C3D8-4AA4-A5B3-4CF4D65ECC7AQ42983047-B91BC53A-A254-47B3-83DE-998D004EF226
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Helicases as antiviral drug targets.
@ast
Helicases as antiviral drug targets.
@en
type
label
Helicases as antiviral drug targets.
@ast
Helicases as antiviral drug targets.
@en
prefLabel
Helicases as antiviral drug targets.
@ast
Helicases as antiviral drug targets.
@en
P2860
P1476
Helicases as antiviral drug targets.
@en
P2860
P304
P356
10.1358/DNP.2003.16.6.829307
P577
2003-07-01T00:00:00Z